Article Publish Status: FREE
Abstract Title:

A new curcuma extract (flexofytol®) in osteoarthritis: results from a belgian real-life experience.

Abstract Source:

Open Rheumatol J. 2014 ;8:77-81. Epub 2014 Oct 17. PMID: 25352926

Abstract Author(s):

Thierry Appelboom, Nathalie Maes, Adelin Albert

Article Affiliation:

Thierry Appelboom

Abstract:

This retrospective observational study summarizes the experiences of 820 patients treated with a new Curcuma extract (Flexofytol®, 4-6 capsules per day), for more than 6 months for various forms of painful osteoarthritis. These experiences were reported by 110 Belgian general practitioners via a questionnaire that included quality-of-life parameters for assessing patient experience. Data were submitted to an independent statistician for analysis. Within the first 6 weeks, Flexofytol® improved patient pain, articular mobility, and quality of life. Excellent tolerance was reported, and more than half of these patients were able to discontinue analgaesic and anti-inflammatory drugs. Patient satisfaction was confirmed bytheir decision to maintain Flexofytol® therapy for more than 6 months. These data must be confirmed with randomized controlled studies. We currently conclude that Flexofytol® which is based on a new preparation of curcumin, is as a potential neutraceutical for the care of patients complaining ofjoint problems, with excellent tolerance and rapid benefits for articular mobility, pain, and quality of life.

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.